- Categories / Pain Relief / Soma Generic
|500mg x 60 pills||$1.25||$75.00|
|500mg x 90 pills||$1.19||$107.50||$5.00|
|500mg x 120 pills||$1.17||$140.00||$10.00|
|500mg x 160 pills||$1.13||$180.00||$20.00|
|350mg x 60 pills||$1.17||$70.00|
|350mg x 90 pills||$1.11||$100.00||$5.00|
|350mg x 120 pills||$0.96||$115.00||$10.00|
|350mg x 160 pills||$0.91||$145.00||$20.00|
Soma (Carisoprodol ) is a medication which relaxes the
muscles by blocking pain sensations between the nerves and the brain.
Soma (Carisoprodol) is the generic form of the prescription drug Soma, which is used to relax muscles and help alleviate pain from muscle spasms.
Soma (Carisoprodol) belongs to a group of drugs known as muscle relaxants. It was originally approved by the Food and Drug Administration (FDA) in 2007. Soma is manufactured by Meda Pharmaceuticals.
How should I use this medicine?
Soma (Carisoprodol) is used short-term to treat muscle pain and discomfort. It is usually used along with rest, physical therapy, and other treatments. It works by helping to relax the muscles.
How Do I take Soma Generic?
Where should I keep my medicine?
Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.
Store at controlled room temperature 20° - 25°C (68° - 77°F).
The recommended dose of SOMA is 350 mg to 500 mg three times a day and at bedtime. The recommended maximum duration of SOMA use is up to two or three weeks.
Soma can cause a few side effects that may affect your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert, becasue SOMA can make you feel dizzy and drowsy. The common side effects include headache, unusually fast heartbeat, low blood pressure, or face flushing may occur.
Active Ingredient: Soma.
SOMA has sedative properties (in the low back pain trials, 13% to 17% of patients who received SOMA experienced sedation compared to 6% of patients who received placebo) [see ADVERSE REACTIONS] and may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a motor vehicle or operating machinery. There have been post-marketing reports of motor vehicle accidents associated with the use of SOMA.
Since the sedative effects of SOMA and other CNS depressants (e.g., alcohol, benzodiazepines, opioids, tricyclic antidepressants) may be additive, appropriate caution should be exercised with patients who take more than one of these CNS depressants simultaneously.
Abuse, Dependence and Withdrawal
Carisoprodol, the active ingredient in SOMA, has been subject to abuse, dependence, withdrawal, misuse, and criminal diversion. Abuse of SOMA poses a risk of overdosage which may lead to death, CNS and respiratory depression, hypotension, seizures, and other disorders.
Post-marketing experience cases of carisoprodol abuse and dependence have been reported in patients with prolonged use and a history of drug abuse. Although most of these patients took other drugs of abuse, some patients solely abused carisoprodol. Withdrawal symptoms have been reported following abrupt cessation of SOMA after prolonged use.
Reported withdrawal symptoms included insomnia, vomiting, abdominal cramps, headache, tremors, muscle twitching, ataxia, hallucinations, and psychosis. One of carisoprodol's metabolites, meprobamate (a controlled substance), may also cause dependence.
To reduce the risk of SOMA abuse, assess the risk of abuse prior to prescribing. After prescribing, limit the length of treatment to three weeks for the relief of acute musculoskeletal discomfort, keep careful prescription records, monitor for signs of abuse and overdose, and educate patients and their families about abuse and on proper storage and disposal.
There have been post-marketing reports of seizures in patients who received SOMA. Most of these cases have occurred in the setting of multiple drug overdoses (including drugs of abuse, illegal drugs, and alcohol).
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long term studies in animals have not been performed to evaluate the carcinogenic potential of carisoprodol.
SOMA was not formally evaluated for genotoxicity. In published studies, carisoprodol was mutagenic in the in vitro mouse lymphoma cell assay in the absence of metabolizing enzymes, but was not mutagenic in the presence of metabolizing enzymes.
Carisoprodol was clastogenic in the in vitro chromosomal aberration assay using Chinese hamster ovary cells with or without the presence of metabolizing enzymes. Other types of genotoxic tests resulted in negative findings.
Carisoprodol was not mutagenic in the Ames reverse mutation assay using S. typhimurium strains with or without metabolizing enzymes, and was not clastogenic in an in vivo mouse micronucleus assay of circulating blood cells.
SOMA was not formally evaluated for effects on fertility. Published reproductive studies of carisoprodol in mice found no alteration in fertility although an alteration in reproductive cycles characterized by a greater time spent in estrus was observed at a carisoprodol dose of 1200 mg/kg/day.
In a 13-week toxicology study that did not determine fertility, mouse testes weight and sperm motility were reduced at a dose of 1200 mg/kg/day. In both studies, the no effect level was 750 mg/kg/day, corresponding to approximately 2.6 times the human equivalent dosage of 350 mg four times a day, based on a body surface area comparison. The significance of these findings for human fertility is not known.
Use In Specific Population
Pregnancy Category C
There are no data on the use of SOMA during human pregnancy. Animal studies indicate that carisoprodol crosses the placenta and results in adverse effects on fetal growth and postnatal survival. The primary metabolite of carisoprodol, meprobamate, is an approved anxiolytic. Retrospective, post-marketing studies do not show a consistent association between maternal use of meprobamate and an increased risk for particular congenital malformations.
Common Side Effects of Carisoprodol
If you have any of the following more common side effects of carisoprodol and they do not go away or they become severe, call your doctor or seek immediate medical care.
- Sleepiness or drowsiness
Some people may also notice dry mouth, dry eyes, constipation, and trouble urinating.
Serious Effects and Reactions
Tell your doctor right away or seek emergency medical care if you experience the following symptoms:
- A very severe skin reaction where the skin becomes extremely red, peels, or develops blisters or large bumps. This is a condition known as erythema multiforme and can be life-threatening.
- Swelling of the lips, tongue, and mouth (angioedema)
- Extreme weakness, poor coordination, or paralysis
- Dizziness generally, or lightheadedness or dizziness when you stand up (orthostatic hypotension)
- Feel agitated or confused
- New infections or feelings of fatigue (these may be related to decreased levels of white and red blood cells, known as pancytopenia)
- You just stopped taking carisoprodol after having taken it for a long time and feel "weird"